But the sugar
The peculiarity of liver cancer is that in the early stages it is almost asymptomatic and the diagnosis is often made by chance during the examination due to other problems. Liver cancer is a rare but dangerous disease. What is the difficulty in diagnosing and treating liver cancer? About this for readers Medpulse tells MD, professor Yuri Patyutko.
See also: Triple strike on a diseased liver
– How often is this disease?
– Primary liver cancer in Russia and in Central Europe is not so common – about 5 cases per 100 thousand people. He is not even included in the “top ten” malignant tumors. Nevertheless, the diagnosis of this disease is a serious problem. Continue reading
The costs of treating cancer usually exceed insurance coverage … So: the economic burden of prostate cancer alone in Russia amounted to 3.7 billion rubles a year. These and other important data were the result of a study conducted by the Research Institute of Clinical and Economic Expertise and Pharmaceutical Economics of the Russian National Research Medical University named after Pirogov.
Prostate cancer (PCa) is one of the most commonly diagnosed oncological diseases in the male population of Russia. Over the past ten years, there has been an increase in the incidence and mortality rates from this disease. So, prostate cancer ranks third (11% of the total) in the structure of the primary incidence of malignant neoplasms. In the period from 2000 to 2010. a high rate of increase in the incidence of prostate cancer was noted – an average of 9.83% per year. According to 2010 data, there is a continuation of the growth trend in mortality rates from prostate cancer – compared with 2009, mortality from prostate cancer increased by 2.1%. Continue reading
In this regard, the Association of International Manufacturers of Medical Devices IMEDA expresses concern that the exclusion of most medical devices from treatment standards may entail serious difficulties in providing medical care in both Russian hospitals and outpatients. In particular, vital products for the provision of surgical care, diagnostic procedures, including determination of sugar levels, in-vitro diagnostics, etc., were excluded from some standards. The concern of the IMEDA Association is the fact that, due to the current situation, the question of confirming financing remains open: the lack of medical devices in the treatment standards may prevent the establishment of a specific quality level for each of the standards, since it will be possible to save on technology and quality.
See also: What fast food does with our brains Continue reading